Connor, Clark & Lunn Investment Management (CC&L)’s Immunogen Inc IMGN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-909,595	Closed	-$17.2M	–	1598
2023 Q2	$17.2M	Buy	909,595 +514,941	+130%	+$6.08M	0.09%	178
2023 Q1	$1.52M	Buy	394,654 +378,881	+2,402%	+$1.61M	0.01%	623
2022 Q4	$78.2K	Buy	+15,773	New	+$85.5K	﹤0.01%	1125
2018 Q1	–	Sell	-133,050	Closed	-$853K	–	827
2017 Q4	$853K	Buy	+133,050	New	+$821K	0.01%	540
2013 Q4	–	Sell	-11,900	Closed	-$208K	–	767
2013 Q3	$208K	Buy	+11,900	New	+$209K	﹤0.01%	455

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s IMGN Position: Q3 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 909,595 shares — an estimated $17.2M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IMGN in Q3 2013 and held it in 5 quarters. The position peaked at $17.2M in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 909,595 Immunogen Inc shares in Q3 2023, an estimated $17.2M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Immunogen Inc in Q3 2013 and held it in 5 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Immunogen Inc position peaked at $17.2M in Q2 2023.
275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2023, filed 13 Nov 2023.